Reviva Pharmaceuticals Holdings RVPH

$ 1.33 -11.67%

Quarterly report 2024-Q3
added 11-14-2024

Reviva Pharmaceuticals Holdings Financial Statements 2011-2024 | RVPH

Annual Financial Statements Reviva Pharmaceuticals Holdings

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	82.8 M	76.3 M	42.7 M	22.5 M	-	-	-	-	-	-	-	-	-
Shares	23.8 M	19.5 M	14.8 M	2.77 M	-	-	-	-	-	-	-	-	-
Historical Prices	3.48	3.91	2.89	8.74	10.5	9.85	-	-	-	-	-	-	-
Net Income	-39.3 M	-28.3 M	-8.52 M	-3.78 M	-847 K	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-39.5 M	-28.2 M	-10.1 M	-2.43 M	-377 K	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	1.45 M	469 K	-	-	-	-	-	-	-	-
EBITDA	-39.5 M	-28.2 M	-10.1 M	-	-376 K	-	-	-	-	-	-	-	-
Operating Expenses	39.5 M	28.2 M	10.1 M	2.43 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	8.08 M	5.36 M	5.25 M	2.14 M	181 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Reviva Pharmaceuticals Holdings

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	33.8 M	30.6 M	29.9 M	27.9 M	23.6 M	22.4 M	21.8 M	20.4 M	19.3 M	18.5 M	18.5 M	14.4 M	18.5 M	12.9 M	9.23 M	2.81 M	2.78 M	2.77 M	2.77 M	2.61 M	2.61 M	2.6 M	2.6 M	2.6 M	2.6 M	1.46 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-8.37 M	-7.86 M	-7.43 M	-	-11.3 M	-11.7 M	-6.85 M	-	-3.52 M	-5.34 M	-7.37 M	-	-2.28 M	-1.61 M	-949 K	-348 K	-659 K	-851 K	-749 K	137 K	750 K	274 K	338 K	263 K	263 K	17.7 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-8.46 M	-8.13 M	-7.92 M	-	-11.6 M	-11.3 M	-6.98 M	-	-3.56 M	-5.52 M	-7.45 M	-	-2.48 M	-1.79 M	-1.87 M	-352 K	-512 K	-777 K	-618 K	-166 K	-331 K	-165 K	-71.1 K	-79.1 K	-79.1 K	-2.33 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-23.7 K	-5.62 K	3.49 K	-	5.19 K	-19	7.66 K	-	-	-	-	-	-	-	-	3.8 K	146 K	99.1 K	130 K	324 K	1.07 M	750 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-3.56 M	-5.52 M	-7.45 M	-	-2.48 M	-1.79 M	-1.87 M	-352 K	-512 K	-777 K	-618 K	-166 K	-331 K	-165 K	-71.1 K	-79.1 K	-79.1 K	-2.33 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	8.46 M	8.13 M	7.92 M	-	11.6 M	11.3 M	6.98 M	-	3.56 M	5.52 M	7.45 M	-	2.48 M	1.79 M	1.87 M	352 K	512 K	777 K	618 K	166 K	331 K	165 K	71.1 K	79.1 K	79.1 K	2.33 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.6 M	2.55 M	2.14 M	-	1.99 M	3.08 M	1.5 M	-	1.26 M	1.01 M	1.62 M	-	1.05 M	1.42 M	1.48 M	-	511 K	741 K	347 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency